Syndax Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352.

CEO

Michael A. Metzger

CEOMichael A. Metzger

Employees

184

Employees184

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2005

Founded2005

Employees

184

Employees184

SNDX Key Statistics

Market cap

1.97B

Market cap1.97B

Price-Earnings ratio

-7.82

Price-Earnings ratio-7.82

Dividend yield

—

Dividend yield—

Average volume

876.34K

Average volume876.34K

High today

$23.22

High today$23.22

Low today

$22.47

Low today$22.47

Open price

$22.62

Open price$22.62

Volume

822.69K

Volume822.69K

52 Week high

$25.34

52 Week high$25.34

52 Week low

$11.22

52 Week low$11.22

SNDX News

Investor's Business Daily 2d

Syndax Pharmaceuticals Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

On Monday, Syndax Pharmaceuticals (SNDX) hit an important technical milestone, with its Relative Strength (RS) Rating rising into the 80-plus percentile with an...

Analyst ratings

92%

of 13 ratings

Buy

92.3%

Hold

7.7%

Sell